Site Search
Displaying results 21 - 30 of 184
Resource | Publications,
The Global Fund Strategy 2017-2022, Investing to End Epidemics, was developed under the leadership of the Board of the Global Fund, with contributions from numerous partners and stakeholders who share common goals in global health. Over a two-year period, in 2014 and 2015, the Board’s Strategy, Investment and Impact Committee led a broadly consultative process to collect the strongest ideas, perspective and guidance to formulate the Strategy.
Resource | Publications,
This publication on the Malaysia National Health Accounts (MNHA) contains twenty years national health expenditure data from 1997 to 2016, estimated using standardised and internationally acceptable National Health Accounts (NHA) methodology.
The reporting format follows closely the MNHA Framework and is kept almost similar to previous reporting format with the addition of a few editorial improvements for ease of reading and new sections.
Resource | Publications,
Health programmes are able to target health interventions for specific diseases or populations, and historically, countries have relied heavily on them to deliver priority services. In low and middle income countries, this organizational approach has been reinforced by donor assistance for priority areas that often leads programmes to operate largely autonomously from one another in seeking to optimize the achievement of a specific objective. This dynamic has implications for how priority interventions are delivered and sustained, sometimes with separate organizational arrangements resulting in inefficient overlaps and duplications. As contexts change, and in particular, as responsibility for funding these programmes shifts more towards domestic resources, maintaining an array of programmes with distinct, separate organizational arrangements is unlikely to be affordable.
This paper presents an approach to conceptualizing and addressing inefficiencies arising from the way that health programmes operate within the context of the overall health system.
Resource | Publications,
This report reflects a new era for the UN. It offers practical solutions to transforming the way the Joint Programme works. As the UN charts out its reform agenda, this report provides the first organizational effort to translate the directions set out in the Quadrennial Comprehensive Policy Review into specific, actionable recommendations on financing, joint working, and accountability. But these recommendations should not stop at the door of the Joint Programme, we encourage Member States as well as our colleagues across the UN Development system to consider these recommendations as they take their own steps towards organizational repositioning, as together, we build a UN fit for purpose in leading the world to achieve the vision of the 2030 Agenda for Sustainable Development, including to leave no one behind.
Resource | Infographics,
Infographics on Sustainable Development Goals (SDGs): Extending Life Expectancy
Resource | Publications,
The purpose of this information note is to support civil society and community groups to design and include community systems strengthening interventions and community-based monitoring activities in funding requests during the 2017-2019 Global Fund funding cycle. This information will be of interest to community groups, key population networks, country coordination mechanism (CCM) members, ministries of health, disease program managers, and health service providers.
Resource | Infographics,
Infographics on Sustainable Development Goals (SDGs): Preventing Premature Deaths
Resource | Publications,
This report provides the latest data on donor government resources available to address HIV in low- and middle-income countries. It is part of a collaborative effort between UNAIDS and the Kaiser Family Foundation that began more than a decade ago, just as new global initiatives were being launched to address the epidemic. This current report provides data on donor government disbursements in 2016, the most recent year available.
Resource | Publications,
Antiretroviral treatment (ART) has radically changed the face of HIV infection, from a lethal disease into a manageable chronic condition.
All 37 million people currently living with HIV are now eligible for ART based on the 2015 WHO Guidelines for ARVs for treatment and prevention - unfortunately, the latest data from December 2016 shows that only 18.2 million of these individuals are currently accessing ART. At the same time, daily antiretroviral regimens are costly and sometimes difficult for patients and most importantly not curative. HIV persists despite even the best treatment, and contributes to the development of non-AIDS morbidity.
Resource | Publications,
In its 13th annual report, the Resource Tracking for HIV Prevention Research & Development Working Group ("Working Group") documents research and development spending for the calendar year 2016 and analyzes funding trends spanning 16 years.
Between 2000 and 2016, the Working Group has tracked over US$17 billion in investment towards biomedical HIV prevention research and development (R&D1) (Figure 1). The 2016 report analyzes over 600 donor-identified disbursements, as well as R&D spending trends for the following prevention options: AIDS vaccines, microbicides, pre-exposure prophylaxis (PrEP), treatment as prevention (TasP), medical male circumcision (VMMC), female condoms, prevention of vertical transmission (PMTCT) and HSV-2 vaccines. Cure research and therapeutic vaccine investments were also tracked as part of a comprehensive analysis of the HIV R&D landscape.
In a constantly evolving field, the Working Group estimates serve as a comparative cross-sectional and retrospective analysis of interventions, funding sources and strategies to evaluate the impact of public policies and to provide support for advocacy. This work also provides the transparency needed for funders, policy makers and HIV/AIDS advocates to best understand HIV prevention R&D investment flows and to generate strategies for the future.